Actively Recruiting
The Hepatitis C Transplant Collaborative
Led by Baylor Research Institute · Updated on 2026-01-22
500
Participants Needed
1
Research Sites
584 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
CONDITIONS
Official Title
The Hepatitis C Transplant Collaborative
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recipient of a proven HCV NAT+ donor heart
- Re-transplant patients will be included
You will not qualify if you...
- Multi-organ transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Baylor Scott & White Health Research Institute
Dallas, Texas, United States, 75246
Actively Recruiting
Research Team
J
Joost Felius, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here